Dr. Latanya Benjamin, MD, FAAD, FAAP, continues her discussion on a 35-year-old female patient with vitiligo by analyzing laboratory workup results and exploring advanced treatment decisions to optimize patient outcomes.
Exploring Afamelanotide for Vitiligo: Insights into the CUV 105 Phase 3 Clinical Trial
The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD
Researchers Report Case of Patient With Mogamulizumab-Induced Vitiligo
ReV Up Your Vitiligo Treatment Strategies
Exploring Genetic Factors in Vitiligo and AA
Discovering Dermatology Times: August 2024 Personalized Vitiligo Care Supplement